Io Biotech, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

IO Biotech, Inc. has ceased operations and filed for Chapter 7 bankruptcy, initiating the liquidation of its assets.
Novo Holdings A/S has significantly reduced its stake in IO Biotech, Inc., selling over 2.5 million shares and ceasing to be a beneficial owner of more than five percent.
Novo Holdings A/S has reduced its beneficial ownership in IO Biotech, Inc. to approximately 7.3% after selling 841,996 shares in a block trade.